Newamsterdam Pharma Company Nv Share Price: NAMS (Newamsterdam Pharma Company Nv) Stock Price Today & Updates | INDmoney

Question 1

What is Newamsterdam Pharma Company Nv share price today?

Accepted Answer

Newamsterdam Pharma Company Nv (NAMS) share price today is {{live_price}}.

Question 2

Can Indians buy Newamsterdam Pharma Company Nv shares?

Accepted Answer

Yes, Indians can invest in the Newamsterdam Pharma Company Nv (NAMS) from India.

With INDmoney, you can buy Newamsterdam Pharma Company Nv at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Newamsterdam Pharma Company Nv at zero transaction cost.

Question 3

How can I buy Newamsterdam Pharma Company Nv shares from India?

Accepted Answer

It is very easy to buy Newamsterdam Pharma Company Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Newamsterdam Pharma Company Nv be purchased?

Accepted Answer

Yes, you can buy fractional shares of Newamsterdam Pharma Company Nv with INDmoney app.

Question 5

What are the documents required to start investing in Newamsterdam Pharma Company Nv stocks?

Accepted Answer

To start investing in Newamsterdam Pharma Company Nv, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Newamsterdam Pharma Company Nv

Accepted Answer

Today’s highest price of Newamsterdam Pharma Company Nv (NAMS) is {{1_rba_end}}.

Today’s lowest price of Newamsterdam Pharma Company Nv (NAMS) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Newamsterdam Pharma Company Nv

Accepted Answer

Today's market capitalisation of Newamsterdam Pharma Company Nv NAMS is 1.5B

Question 8

What is the 52 Week High and Low Range of Newamsterdam Pharma Company Nv

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Newamsterdam Pharma Company Nv is down from its 52 Week High?

Accepted Answer

Newamsterdam Pharma Company Nv (NAMS) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Newamsterdam Pharma Company Nv is up from its 52 Week low?

Accepted Answer

Newamsterdam Pharma Company Nv (NAMS) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Newamsterdam Pharma Company Nv?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Newamsterdam Pharma Company Nv

Accepted Answer

Dr. Michael Harvey Davidson FACC, Facp., M.D. is the current Chief Executive Officer (CEO) of Newamsterdam Pharma Company Nv.

Period	Newamsterdam Pharma Company Nv	Index (Russel 2000)
3 Months	-15.03%	0.0%
6 Months	-21.61%	0.0%
1 Year	62.54%	0.0%
3 Years	58.45%	-22.3%

Market Capitalization	1.5B
Book Value	$4.3
Earnings Per Share (EPS)	-2.62
Wall Street Target Price	37.0

Profit Margin	0.0%
Operating Margin TTM	-2306.93%

Return On Assets TTM	-27.15%
Return On Equity TTM	-54.08%

Revenue TTM	7.4M
Revenue Per Share TTM	0.09
Quarterly Revenue Growth YOY	32.7%
Gross Profit TTM	0.0
EBITDA	-208.6M
Diluted Eps TTM	-2.62
Quarterly Earnings Growth YOY	0.0

Newamsterdam Pharma Company Nv (NAMS)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-2.44
EPS Estimate Next Year	-1.74
EPS Estimate Current Quarter	-0.58
EPS Estimate Next Quarter	-0.51

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Newamsterdam Pharma Company Nv	4.73%	-21.61%	62.54%	58.45%	58.45%
Regeneron Pharmaceuticals, Inc.	5.97%	16.25%	37.11%	69.18%	305.56%
Novo Nordisk A/s	9.99%	-3.52%	34.24%	158.74%	417.73%
Alnylam Pharmaceuticals, Inc.	-5.15%	64.67%	22.72%	31.08%	198.44%
Vertex Pharmaceuticals Incorporated	0.45%	14.0%	36.06%	143.5%	167.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Newamsterdam Pharma Company Nv	30.14	NA	NA	-2.44	-0.54	-0.27	NA	4.3
Regeneron Pharmaceuticals, Inc.	29.93	29.93	1.54	45.05	0.17	0.08	NA	261.41
Novo Nordisk A/s	44.01	44.01	1.98	3.44	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.55	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.57	0.32	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Newamsterdam Pharma Company Nv	Buy	$1.5B	58.45%	30.14	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$124.7B	305.56%	29.93	32.04%
Novo Nordisk A/s	Buy	$585.3B	417.73%	44.01	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$32.3B	198.44%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$120.9B	167.72%	32.84	-4.74%

Organization	Newamsterdam Pharma Company Nv
Employees	57
CEO	Dr. Michael Harvey Davidson FACC, Facp., M.D.
Industry	Miscellaneous